NCT00116402 - A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

October 31, 2009

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone and salmeterol

"1. will start with fluticasone 220 mcg BID first and then crossover to combination therapy with salmeterol 50 mcg BID~2. will start with salmeterol 50 mcg BID first and then crossover to combination therapy with fluticasone 220 mcg BID."

Trial Locations (1)

60637

Department of Medicine, Pulmonary & Critical Care Section, The University of Chicago, Chicago